AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Pradaxa bind12/19/2023 Dabigatran etexilate was approved as a generic medication in the United States in 2020. In 2020, it was the 306th most commonly prescribed medication in the United States, with more than 1 million prescriptions. It is on the World Health Organization's List of Essential Medicines. ĭabigatran was approved for medical use in the United States in 2010. Compared to warfarin it has fewer interactions with other medications. Use is not recommended during pregnancy or breastfeeding. In cases of severe bleeding, it can be reversed with the antidote, idarucizumab. Other side effects may include bleeding around the spine and allergic reactions such as anaphylaxis. Ĭommon side effects include bleeding and gastritis. In a meta analysis of 7 different studies, there was no benefit of dabigatran over warfarin in preventing ischemic stroke however, dabigatran were associated with a lower hazard for intracranial bleeding compared with warfarin, but also had a higher risk of gastrointestinal bleeding relative to warfarin. It is used as an alternative to warfarin and does not require monitoring by blood tests. ![]() Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation.
0 Comments
Read More
Leave a Reply. |